The DEAD-box RNA helicase DDX5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer

Li, 2021, Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy, Am. J. Cancer Res., 11, 5190 Liu, 2002, p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5’ splice site duplex, Mol. Cell. Biol., 22, 5443, 10.1128/MCB.22.15.5443-5450.2002 Jalal, 2007, Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation, Nucleic Acids Res., 35, 3590, 10.1093/nar/gkm058 Wang, 2009, P68 RNA helicase is a nucleocytoplasmic shuttling protein, Cell Res., 19, 1388, 10.1038/cr.2009.113 Yang, 2005, Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation, Mol. Cancer Res., 3, 355, 10.1158/1541-7786.MCR-05-0022 Clark, 2008, The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer, Cancer Res., 68, 7938, 10.1158/0008-5472.CAN-08-0932 Yang, 2006, P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin, Cell, 127, 139, 10.1016/j.cell.2006.08.036 Bates, 2005, The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor, EMBO J., 24, 543, 10.1038/sj.emboj.7600550 Jensen, 2008, p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation, J. Cell. Biochem., 103, 10.1002/jcb.21526 Caretti, 2006, The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation, Dev. Cell, 11, 547, 10.1016/j.devcel.2006.08.003 Dai, 2014, P68 RNA helicase as a molecular target for cancer therapy, J. Exp. Clin. Cancer Res., 33, 64, 10.1186/s13046-014-0064-y Tabassum, 2022, DEAD-box RNA helicases with special reference to p68: unwinding their biology, versatility, and therapeutic opportunity in cancer, Genes Dis., 10.1016/j.gendis.2022.02.008 Sarkar, 2016, DEAD box RNA helicases: crucial regulators of gene expression and oncogenesis, Front. Biosci. (Landmark Ed.), 21, 225, 10.2741/4386 Xu, 2022, DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression, Front. Oncol., 12 Zhao, 2022, Wnt signaling in colorectal cancer: pathogenic role and therapeutic target, Mol. Cancer, 21, 144, 10.1186/s12943-022-01616-7 Bienz, 2000, Linking colorectal cancer to Wnt signaling, Cell, 103, 311, 10.1016/S0092-8674(00)00122-7 Dekker, 2019, Colorectal cancer, Lancet (Lond.Engl.), 394, 1467, 10.1016/S0140-6736(19)32319-0 Wang, 2022, Mechanisms and prospects of circular RNAs and their interacting signaling pathways in colorectal cancer, Front. Oncol., 12 Lotfollahzadeh, 2022, Colon cancer Chen, 2022, Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota, Front. Microbiol., 13 Jia, 2022, Colorectal cancer vaccines: the current scenario and future prospects, Front. Immunol., 13, 10.3389/fimmu.2022.942235 Shaukat, 2022, Current and future colorectal cancer screening strategies, Nat. Rev. Gastroenterol. Hepatol., 19, 521, 10.1038/s41575-022-00612-y Kim, 2006, The Forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer, Cancer Res., 66, 2153, 10.1158/0008-5472.CAN-05-3003 Kong, 2013, Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer, Cancer Res., 73, 3987, 10.1158/0008-5472.CAN-12-3859 Zhang, 2016, Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer, Clin. Transl. Oncol. Off. Publ. Fed. Spanish Oncol. Soc. Natl. Cancer Inst. Mex., 18, 527 Xu, 2013, FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis, PLoS One, 8 Wen, 2014, Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer, J. Transl. Med., 12, 134, 10.1186/1479-5876-12-134 Liu, 2006, FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells, Cancer Res., 66, 3593, 10.1158/0008-5472.CAN-05-2912 Chu, 2012, FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer, Acta Histochem., 114, 755, 10.1016/j.acthis.2012.01.002 Fuller-Pace, 2011, RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development, Future Oncol., 7, 239, 10.2217/fon.11.1 Castaneda, 2022, Forkhead box transcription factors: double-edged swords in cancer, Cancer Res., 82, 2057, 10.1158/0008-5472.CAN-21-3371 Laissue, 2019, The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis, Mol. Cancer, 18, 5, 10.1186/s12943-019-0938-x Gong, 2012, FoxM1 and Wnt/β-catenin signaling in glioma stem cells, Cancer Res., 72, 5658, 10.1158/0008-5472.CAN-12-0953 Sher, 2022, Dysregulated FOXM1 signaling in the regulation of cancer stem cells, Semin. Cancer Biol., 10.1016/j.semcancer.2022.07.009 Chandrashekar, 2017, UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19, 649, 10.1016/j.neo.2017.05.002 Yang, 2007, Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression, J. Biol. Chem., 282, 16811, 10.1074/jbc.M610488200 Janknecht, 2010, Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17), Am. J. Transl. Res., 2, 223 Chen, 2013, β-Catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis, PLoS One, 8 Yang, 2019, FOXM1 promotes the growth and metastasis of colorectal cancer via activation of β-catenin signaling pathway, Cancer Manag. Res., 11, 3779, 10.2147/CMAR.S185438 Bilir, 2019, The possible interactions and therapeutic roles of lithium chloride and midkine on cancer treatment, Crit. Rev. Oncog., 24, 35, 10.1615/CritRevOncog.2018029410 Jamieson, 2011, Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop, Traffic, 12, 983, 10.1111/j.1600-0854.2011.01207.x Huang, 2017, IWP2 impairs the development of porcine somatic cell nuclear transfer embryos via Wnt signaling pathway inactivation, Biomed. Rep., 7, 36, 10.3892/br.2017.918 Oloumi, 2006, Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells, Oncogene, 25, 7747, 10.1038/sj.onc.1209752 Nie, 2020, Emerging roles of wnt ligands in human colorectal cancer, Front. Oncol., 10, 1341, 10.3389/fonc.2020.01341 Zhang, 2012, The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer, Hum. Pathol., 43, 1044, 10.1016/j.humpath.2011.08.013 Sarkar, 2015, The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis, Oncogene, 34, 5843, 10.1038/onc.2015.42 Fuller-Pace, 2012, DEAD-box RNA helicases as transcription cofactors, Methods Enzymol., 511, 347, 10.1016/B978-0-12-396546-2.00016-4 Smale, 2010, Luciferase assay Gartel, 2011, Thiostrepton, proteasome inhibitors and FOXM1, Cell Cycle, 10, 4341, 10.4161/cc.10.24.18544 Chen, 2021, USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1, Cell Death Dis., 12, 887, 10.1038/s41419-021-04163-z Krieghoff-Henning, 2017, Cancer – an overview, Med. Monatsschr. Pharm., 40, 48 Khare, 2019, RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer, J. Exp. Clin. Cancer Res., 38, 330, 10.1186/s13046-019-1304-y Guturi, 2012, Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells, J. Biol. Chem., 287, 18287, 10.1074/jbc.M111.324798 Sarkar, 2017, The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis, Oncogene, 36, 3080, 10.1038/onc.2016.449 Kal, 2022, Wnt/β-catenin signaling and p68 conjointly regulate CHIP in colorectal carcinoma, Biochim. Biophys. Acta Mol. Cell Res., 1869, 10.1016/j.bbamcr.2021.119185 Raychaudhuri, 2011, FoxM1: a master regulator of tumor metastasis, Cancer Res., 71, 4329, 10.1158/0008-5472.CAN-11-0640 Wang, 2011, RNA helicase DDX5 regulates MicroRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells, Mol. Cell. Proteomics, 11 Ling, 2022, FL118, acting as a ‘molecular glue degrader’, binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy, Clin. Transl. Med., 12, 10.1002/ctm2.881 Lin, 2013, Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy, Oncol. Rep., 30, 1739, 10.3892/or.2013.2654 Varghese, 2019, FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression, Sci. Rep., 9, 1505, 10.1038/s41598-018-38017-0 Jiang, 2015, Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma, J. Cancer Res. Clin. Oncol., 141, 971, 10.1007/s00432-014-1872-3 Madhi, 2022, FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation, Adv. Sci., 9 Hegde, 2011, The transcription factor FOXM1 is a cellular target of the natural product thiostrepton, Nat. Chem., 3, 725, 10.1038/nchem.1114 Kongsema, 2019, Molecular mechanism of forkhead box M1 inhibition by thiostrepton in breast cancer cells, Oncol. Rep., 42, 953 Capasso, 2019, First-in-class phosphorylated-p68 inhibitor RX-5902 inhibits β-catenin signaling and demonstrates antitumor activity in triple-negative breast cancer, Mol. Cancer Ther., 18, 1916, 10.1158/1535-7163.MCT-18-1334 Shinji, 2022, Recent advances in the treatment of colorectal cancer: a review, J. Nippon Med. Sch., 89, 246, 10.1272/jnms.JNMS.2022_89-310 Das, 2016, Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: a pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis, Cell. Signal., 28, 675, 10.1016/j.cellsig.2016.03.007 Ahmed, 2015, Exosome-mediated delivery of the intrinsic C-terminus domain of PTEN protects it from proteasomal degradation and ablates tumorigenesis, Mol. Ther., 23, 255, 10.1038/mt.2014.202 Bhattacharya, 2015, HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP, Cell. Oncol. (Dordr.), 38, 265, 10.1007/s13402-015-0228-6 Ghosh, 2003, A viral mechanism for remodeling chromatin structure in G0 cells, Mol. Cell, 12, 255, 10.1016/S1097-2765(03)00225-9 Datta, 2019, Promyelocytic leukemia (PML) gene regulation: implication towards curbing oncogenesis, Cell Death Dis., 10, 656, 10.1038/s41419-019-1889-2 Choudhury, 2010, A robust automated measure of average antibody staining in immunohistochemistry images, J. Histochem. Cytochem. Off. J. Histochem. Soc., 58, 95, 10.1369/jhc.2009.953554 Bhattacharya, 2018, Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases, Signal Transduct. Target. Ther., 3, 17, 10.1038/s41392-018-0012-y Franken, 2006, Clonogenic assay of cells in vitro, Nat. Protoc., 1, 2315, 10.1038/nprot.2006.339 Pozarowski, 2004, Analysis of cell cycle by flow cytometry, Methods Mol. Biol., 281, 301